Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC in Adult Upper Limb Spasticity
NCT04815967Phase 3Terminated
- Sponsor
- MDD US Operations
- Start
- Nov 2021
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of botulinum toxin type b in Upper limb spasticity, sponsored by MDD US Operations. Started Nov 2021; status: terminated.
02
Drugs
botulinum toxin type b
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT04815967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815967.